Table 3 PLS-DA classification results of HER-2 status in tumors with different ER and PgR status
From: Metabolic characterization of triple negative breast cancer
Total b/p | HER-2neg b/p | HER-2pos b/p | CV accuracy % | CV Sensitivity % | CV Specificity % | Permutation p-value | |
|---|---|---|---|---|---|---|---|
HER-2neg vs HER-2pos in ERneg | 41/30 | 26/19 | 15/11 | 70.1 | 63.3 | 76.8 | 0.013 |
HER-2neg vs HER-2pos in ERpos | 65/43 | 40/24 | 25/19 | 66.1 | 67.9 | 64.3 | 0.017 |
HER-2neg vs HER-2pos in PgRneg | 59/42 | 33/24 | 26/18 | 68.8 | 65.3 | 72.3 | 0.006 |
HER-2neg vs HER-2pos in PgRpos | 47/31 | 33/19 | 14/12 | 70.1 | 68.3 | 71.8 | 0.014 |